Skip to product information
1 of 2

Elanco

Vira Shield 6+VL5 HB

Vira Shield 6+VL5 HB

Regular price $47.72 USD
Regular price Sale price $47.72 USD
Sale Sold out
Shipping calculated at checkout.
NOTIFY ME WHEN IN STOCK
Size

Vira Shield 6+VL5 HB is a killed virus and bacterin for the vaccination of healthy cattle against IBR, PI3, BRSV, cytopathic and noncytopathic BVD Type 1, noncytopathic BVD Type 2; Vibrio (Campylobacter fetus); and the 5 most common strains of Lepto, including the U.S. strain of L. hardjo-bovis. The DOI for BVD Type 2 is at least 11 months; C. fetus and L. hardjo-bovis at least 1 year.

 For use in all classes of cattle, including pregnant cows, heifers and calves nursing pregnant cows. Vaccinate dairy cows during the dry off period. Contains Xtend® SP adjuvant which provides long-lasting immune system stimulation that helps release antigens over time.

Please see shipping information regarding vaccines before placing order. Free shipping on vaccine orders over $150.

Vira Shield 6+VL5 HB Features & Benefits

  • More calves, less stress
  • Allows cows to have improved reproductive performance
  • 12-month DOI for L. hardjo-bovis, the most common cause of lepto in the U.S.
  • Provides protection against IBR abortion for up to 8 months post-vaccination
  • Safe and powerful inactivated vaccine provides comprehensive protection against respiratory, reproductive and leptospirosis diseases

Directions for Use:

Shake well before using. Administer 5 mL subcutaneously 2 to 4 weeks prior to breeding. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate with Vira Shield 6+ L5 HB in 4 to 5 weeks. 

Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency, consultation with a veterinarian is recommended.

Precautions: 

Store out of direct sunlight at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for 3 to 6 days following vaccination. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

 

 

Manufacturer and/or Label Information

ELANCO US, INC.
Farm Animal Business
Distributed by ELANCO US, INC.
1447 140TH ST., LARCHWOOD, IA, 51241
Customer Service: 800-782-8977
Main Switchboard: 317-433-4800
Technical Service: 800-843-4441
Website: www.elanco.us
Email: elanco@elanco.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.
VIRA SHIELD™ 6+VL5 HB

Elanco US (Farm Animal)

Bovine Rhinotracheitis-Virus Diarrhea-Parainfluenza 3-Respiratory Syncytial Virus Vaccine

Killed Virus

Campylobacter Fetus-Leptospira Canicola-Grippotyphosa-Hardjo-Icterohaemorrhagiae-Pomona Bacterin

For Use In Animals Only

INDICATIONS: This product has been shown to be effective for the vaccination of healthy cattle, against disease caused by infectious bovine rhinotracheitis (IBR), bovine virus diarrhea (BVD Type 1 and BVD Type 2), parainfluenza Type 3 (PI3), and bovine respiratory syncytial (BRSV) viruses and Campylobacter fetus, Leptospira canicola, grippotyphosa, hardjo-bovis, icterohaemorrhagiae, and pomona. The duration of immunity for BVD Type 2 is at least 11 months and for C. fetus and L. hardjo-bovis is at least 12 months. The duration of immunity for the other antigens in this product have not been determined. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.

This product has been shown effective against hardjo bovis kidney colonization, urinary shedding and reproductive tract infection. Vaccinated animals subsequently exposed to L. borgpetersenii serovar hardjo (type hardjo bovis) have been shown to clear renal infections within 8 weeks of exposure. Produced from non-cytopathic (BVD Type 1 and BVD Type 2) and cytopathic (BVD Type 1) isolates. This product is safe for use in pregnant cows and heifers.

ADJUVANT: Xtend™ SP.

DIRECTIONS: Shake well before using. Administer 5 mL subcutaneously 2 to 4 weeks prior to breeding. In accordance with Beef Quality Assurance guidelines, this product should be administered subcutaneously (under the skin) in the neck. Revaccinate with Vira Shield 6+ L5 HB (Code 4465.20) in 4 to 5 weeks. Historically, annual revaccination with a single dose has been recommended for this product. The need for this booster has not been established. For advice on revaccination frequency, consultation with a veterinarian is recommended.

PRECAUTIONS: Store out of direct sunlight at 2° to 8°C (35° to 46°F). DO NOT FREEZE. Use entire contents when first opened. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Milk reduction and transient depression may be observed in lactating dairy cows for 3 to 6 days following vaccination. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.

VLN/PCN: 196/44B5.20

Elanco US Inc., Fort Dodge, IA 50501 USA; 800-428-4441

Vira Shield, Xtend, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

10 Doses

50 mL

YL102792A

50 Doses

250 mL

YL102792B

CPN: 1114105.7

Dimensions

Care information

View full details